 |
 |
 |
|
COPEDOL: a two-year French multicentric, observational, longitudinal retro-prospective study in pretreated HIV-1-infected patients starting dolutegravir based regimen due to treatment failure
|
|
|
17th European AIDS Conference, November 6-9, 2019, Basel
Reported by Jules Levin
R LANDMAN,1 AG MARCELIN,2 M BENNANI,3 C PHILIPPE,3 P KOUSIGNIAN,4 L FINKIELSZTEJN,4 L ROUSTAND,4 G NACHBAUR,5 V POURCHER2
1Hôpital Bichat, Paris, France; 2Hopital de la Pitié-Salpêtrière, Paris, France; 3QUALEES, Paris, France; 4ViiV Healthcare, Rueil-Malmaison, France; 5GSK, Rueil-Malmaison, France




References
1, Kandel et al. Drug Des Devel Ther. 2015; 9: 3547-55. 2. Cahn et al. Lancet 2013; 382: 700-8. 3. Castagna et al. J Infect Dis. 2014; 210: 354-62.
|
|
|
 |
 |
|
|